Latest filing published 19 Feb 2026 for Precision Biosciences INC.
This profile gathers the share dealings of Dario Scimeca in Precision Biosciences Inc, where the filings describe the role as senior executive. We count 16 filings; the first trade dates from 28 February 2020 and the latest from 17 February 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 19 February 2026 with an option exercise in Precision Biosciences Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations